Search research articles
Contact Us
Filters
Showing results (11-20 of 129) with videos related to
Page
of 13
Sort By:
The Journal of Pharmacy and Pharmacology
|
January 1, 1996
In-vitro evaluation of biphenylyl acetic acid-beta-cyclodextrin conjugates as colon-targeting prodrugs: drug release behaviour in rat biological media
F Hirayama, K Minami, K Uekama
Blood
|
June 1, 1997
Clonal proliferation and cytokine requirement of murine progenitors for natural killer cells
Y Aiba, F Hirayama, M Ogawa
The Journal of Pharmacy and Pharmacology
|
June 1, 1994
In-vivo and in-vitro evaluations of a modified-release oral dosage form of nifedipine by hybridization of hydroxypropyl-beta-cyclodextrin and hydroxypropylcelluloses in dogs
Z Wang, F Hirayama, K Uekama
Journal of Pharmaceutical Sciences
|
June 11, 1998
Colon-specific drug delivery based on a cyclodextrin prodrug: release behavior of biphenylylacetic acid from its cyclodextrin conjugates in rat intestinal tracts after oral administration
K Minami, F Hirayama, K Uekama
Journal of Pharmaceutical Sciences
|
January 6, 1999
Solubility and mass and nuclear magnetic resonance spectroscopic studies on interaction of cyclosporin A with dimethyl-alpha- and -beta-cyclodextrins in aqueous solution
K Miyake, F Hirayama, K Uekama
Journal of Pharmaceutical Sciences
|
February 1, 1990
Slow-release characteristics of diltiazem from ethylated beta-cyclodextrin complexes
Y Horiuchi, F Hirayama, K Uekama
The Journal of Pharmacy and Pharmacology
|
February 1, 1995
In-vivo and in-vitro correlation for delayed-release behaviour of a molsidomine/O-carboxymethyl-O-ethyl-beta-cyclodextrin complex in gastric acidity-controlled dogs
T Horikawa, F Hirayama, K Uekama
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan
|
October 1, 1991
[Improvement of stability and bioavailability of 1-hexylcarbamoyl-5-fluorouracil (HCFU) by O-carboxymethyl-O-ethyl-beta- cyclodextrin]
Y Horiuchi, F Hirayama, K Uekama
Journal of Pharmaceutical Sciences
|
April 3, 1999
Characterization of tolbutamide polymorphs (Burger's forms II and IV) and polymorphic transition behavior
K Kimura, F Hirayama, K Uekama
Experimental Hematology
|
August 1, 1996
Modulation of early B lymphopoiesis by interleukin-3
T C Ball, F Hirayama, M Ogawa
Page
of 13
Search research articles
Search
Showing results (11-20 of 129) with videos related to
Sort By:
Page
of 13
The Journal of Pharmacy and Pharmacology
|
January 1, 1996
In-vitro evaluation of biphenylyl acetic acid-beta-cyclodextrin conjugates as colon-targeting prodrugs: drug release behaviour in rat biological media
F Hirayama, K Minami, K Uekama
Blood
|
June 1, 1997
Clonal proliferation and cytokine requirement of murine progenitors for natural killer cells
Y Aiba, F Hirayama, M Ogawa
The Journal of Pharmacy and Pharmacology
|
June 1, 1994
In-vivo and in-vitro evaluations of a modified-release oral dosage form of nifedipine by hybridization of hydroxypropyl-beta-cyclodextrin and hydroxypropylcelluloses in dogs
Z Wang, F Hirayama, K Uekama
Journal of Pharmaceutical Sciences
|
June 11, 1998
Colon-specific drug delivery based on a cyclodextrin prodrug: release behavior of biphenylylacetic acid from its cyclodextrin conjugates in rat intestinal tracts after oral administration
K Minami, F Hirayama, K Uekama
Journal of Pharmaceutical Sciences
|
January 6, 1999
Solubility and mass and nuclear magnetic resonance spectroscopic studies on interaction of cyclosporin A with dimethyl-alpha- and -beta-cyclodextrins in aqueous solution
K Miyake, F Hirayama, K Uekama
Journal of Pharmaceutical Sciences
|
February 1, 1990
Slow-release characteristics of diltiazem from ethylated beta-cyclodextrin complexes
Y Horiuchi, F Hirayama, K Uekama
The Journal of Pharmacy and Pharmacology
|
February 1, 1995
In-vivo and in-vitro correlation for delayed-release behaviour of a molsidomine/O-carboxymethyl-O-ethyl-beta-cyclodextrin complex in gastric acidity-controlled dogs
T Horikawa, F Hirayama, K Uekama
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan
|
October 1, 1991
[Improvement of stability and bioavailability of 1-hexylcarbamoyl-5-fluorouracil (HCFU) by O-carboxymethyl-O-ethyl-beta- cyclodextrin]
Y Horiuchi, F Hirayama, K Uekama
Journal of Pharmaceutical Sciences
|
April 3, 1999
Characterization of tolbutamide polymorphs (Burger's forms II and IV) and polymorphic transition behavior
K Kimura, F Hirayama, K Uekama
Experimental Hematology
|
August 1, 1996
Modulation of early B lymphopoiesis by interleukin-3
T C Ball, F Hirayama, M Ogawa
Page
of 13